Dr Gertraud Unterrainer Joins ProBioGen as Chief Financial Officer


ProBioGen AG announced the appointment of Dr Gertraud Unterrainer to Chief Financial Officer. Dr Unterrainer will complement and strengthen ProBioGen's current management team consisting of Michael Schlenk, CEO, and Dr Uwe Marx, CSO.

Dr Unterrainer previously served as Chief Financial Officer of Biovertis AG, Vienna and Munich. Prior to that, she was investment manager of an Austrian seed fund and a consultant at McKinsey & Company. Dr Unterrainer has extensive experience in financial management, operations, and capital market relations and has been responsible for numerous financial transactions and M&A activities in the healthcare field.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances